Market LIVE
Published markets; coverage varies by country
Product profile · United States

ALUNBRIG

 ·  Patent Litigation & Settlement History ↓

IngredientBRIGATINIB
Application typeNDA
Application208772
Product001
Dosage formTABLET
RouteORAL
Strength30MG
Approval date2017-04-28
Marketing statusPrescription
Status event—
ApplicantTAKEDA PHARMS USA
Product source

Current GenericRadar decision

Year2031
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeTRUE_DS_PATENT
Anchor date2031-04-28
Patent anchor2031-04-28
Exclusivity anchor2024-04-28
Protection date2035-11-10
First Final ANDA—
Status event—

POST_ANCHOR_RIGHTS_REMAIN; canonical=2031-04-28; exact Final ANDA not directly identified; not generic absence; USER_DECISION_REQUIRED applied current best classification

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
92730772029-05-21U U-2837NYU
| B1C0201 issued-claim review2026-10-14: U
———
92730772029-05-21ORANGE_BOOK U-2837NYU
English description not available.
———
90124622031-04-28DS —YNTRUE_DS
| B1C0201 issued-claim review2026-10-14: TRUE_DS
———
90124622031-04-28ORANGE_BOOK —YNTRUE_DS
English description not available.
———
96112832034-04-10U U-2837NNU
| B1C0201 issued-claim review2026-10-14: U
———
96112832034-04-10ORANGE_BOOK U-2837NNU
English description not available.
———
103850782035-11-10DS/DP/U U-2837NNOTHER
| B1C0201 issued-claim review2026-10-14: OTHER
———
103850782035-11-10ORANGE_BOOK U-2837NNOTHER
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2017-04-282022-04-28English description not available.YY2022-04-28Source
I-8472020-05-222023-05-22English description not available.NN—Source
ODE-1422017-04-282024-04-28English description not available.NN—Source
ODE-3002020-05-222027-05-22English description not available.NN——Source
ODE-3002020-05-222027-05-22English description not available.NN—Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (9)
TypeDateRoleBasisSource
PATENT2029-05-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2031-04-28CANONICAL_ANCHOREnglish description not available.Source
PATENT2034-04-10FTO_TAILEnglish description not available.Source
PATENT2035-11-10FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2031-04-28CANONICAL_DECISIONPOST_ANCHOR_RIGHTS_REMAIN; canonical=2031-04-28; exact Final ANDA not directly identified; not generic absence; USER_DECISION_REQUIRED applied current best classificationSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.